Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease
2001
PhysioBank, PhysioToolkit, and PhysioNet
2000 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Sudden Cardiac Death in Patients with Chronic Kidney Disease: Prevention Is the sine qua non
2011
Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome
2014
Neural mechanisms of atrial fibrillation
2011
Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation
2002
The impact of ethnicity on response to antihypertensive therapy
1996
An Acute Model for Atrial Fibrillation Arising from a Peripheral Atrial Site: Evidence for Primary and Secondary Triggers
2008
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association
2012
Neural mechanisms of atrial arrhythmias
2011
Sleep-disordered breathing in African-American elderly.
1995
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Echocardiographic Left Ventricular Mass and Electrolyte Intake Predict Arterial Hypertension
1991
Performance Characteristics According to Playing Position in Elite Soccer
2007 Standout
Genetic Variation and Physical Performance
2004
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Racial Differences in Blood Pressure Control: Potential Explanatory Factors
2006
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Spatially Distributed Dominant Excitation Frequencies Reveal Hidden Organization in Atrial Fibrillation in the Langendorff‐Perfused Sheep Heart
2000
Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
1992 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Mitochondrial criticality: A new concept at the turning point of life or death
2005
Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome—role of Purkinje fiber network
2009
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Temporal Organization of Atrial Activity and Irregular Ventricular Rhythm During Spontaneous Atrial Fibrillation:
2000
Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome
2014
Recent advances in the molecular pathophysiology of atrial fibrillation
2011
Electrocardiographic left ventricular scar burden predicts clinical outcomes following infarct-related ventricular tachycardia ablation
2013
Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise
1990
Epicardial Ventricular Tachycardia Ablation
2010
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
PATHOPHYSIOLOGY AND TREATMENT IMPLICATIONS OF HYPERTENSION IN THE AFRICAN-AMERICAN POPULATION
1997
The path to ubiquitous and low-cost organic electronic appliances on plastic
2004 StandoutNature
Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006)
2008
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Nonchannel drug targets in atrial fibrillation
2004
Spatiotemporal evolution of ventricular fibrillation
1998 Nature
Spatial and temporal organization during cardiac fibrillation
1998 Nature
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Antecedents of adherence to medical recommendations: Results from the medical outcomes study
1992
Noninvasive Identification of Ventricular Tachycardia-Related Conducting Channels Using Contrast-Enhanced Magnetic Resonance Imaging in Patients With Chronic Myocardial Infarction
2011
Ventricular arrhythmias originating from papillary muscles in the right ventricle
2010
A Novel Rule-Based Algorithm for Assigning Myocardial Fiber Orientation to Computational Heart Models
2012 Standout
Take Control of Your Blood pressure (TCYB) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure control
2008
Why Is Left Ventricular Hypertrophy So Predictive of Morbidity and Mortality?
1999
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Enhanced Detection Criteria in Implantable Cardioverter-Defibrillators to Avoid Inappropriate Therapy
1996
Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
2011
Adenosine‐Induced Ventricular Arrhythmias in Patients with Supraventricular Tachycardias
2008
Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions
2016
Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐Study
2009
Ethnicity and Renal Disease: Lessons From the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study
1993
Post-Infarction Ventricular Arrhythmias Originating in Papillary Muscles
2008
A model for human ventricular tissue
2004 Standout
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis
2016 Standout
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation
2013
Epidemiology of Obstructive Sleep Apnea
2002 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Preventing ventricular fibrillation by flattening cardiac restitution
2000
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy
2003
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Mapping-guided ablation of pulmonary veins to cure atrial fibrillation
2000
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
2009 Standout
Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans.
1993
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Ethnic and Gender Differences in Ambulatory Blood Pressure Trajectories
2006
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Superior Vena Cava
2000
Aerobic fitness and the diurnal rhythm of blood pressure in adolescents.
1990
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Vortex dynamics in three-dimensional continuous myocardium with fiber rotation: Filament instability and fibrillation
1998
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Effects of simulated ischemia on spiral wave stability
2001
Catheter Ablation for Paroxysmal Atrial Fibrillation
2003
Atrial Fibrillation Originating From Persistent Left Superior Vena Cava
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Atrial Electroanatomic Remodeling After Circumferential Radiofrequency Pulmonary Vein Ablation
2001
The Intrinsic Autonomic Nervous System in Atrial Fibrillation: A Review
2012
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Complications of Catheter Ablation of Ventricular Tachycardia
2014
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias
2013
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
2009
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Quantification of Effects of Global Ischemia on Dynamics of Ventricular Fibrillation in Isolated Rabbit Heart
1998
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Chaos and the Transition to Ventricular Fibrillation
1999
Why Is Left Ventricular Hypertrophy So Predictive of Morbidity and Mortality?
1999
Left ventricular mass and cardiovascular reactivity in young men.
1994
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Ventricular Fibrillation
2000
Exercise and Hypertension
2004 Standout
Nerve Sprouting and Sympathetic Hyperinnervation in a Canine Model of Atrial Fibrillation Produced by Prolonged Right Atrial Pacing
2001
Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study
1999
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Spatiotemporal Periodicity During Atrial Fibrillation in the Isolated Sheep Heart
1998
Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy
2013
Spatiotemporal Heterogeneity in the Induction of Ventricular Fibrillation by Rapid Pacing
1999
Update on cardiac stem cell therapy in heart failure
2012
Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis.
2004 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Tracking restoration in natural and urban field settings
2003 Standout
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Periodicity, Mixed-Mode Oscillations, and Quasiperiodicityin a Rhythm-Generating Neural Network
2002
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Role of Papillary Muscle in the Generation and Maintenance of Reentry During Ventricular Tachycardia and Fibrillation in Isolated Swine Right Ventricle
1999
Percutaneous Left Ventricular Assist Devices in Ventricular Tachycardia Ablation
2014
Silent and non‐silent thromboembolic events after ventricular tachycardia ablation: Modifiable risk with postprocedure anticoagulation?
2019
Works of Chun Hwang being referenced
Underdetection of ventricular tachycardia by algorithms to enhance specificity in a tiered-therapy cardioverter-defibrillator
1994
Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart
2010
Selective Atrionodal Input Ablation for Induction of Proximal Complete Heart Block with Stable Junctional Escape Rhythm in Patients with Uncontrolled Atrial Fibrillation
2003
Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillation
2010
The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias
2000
Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation
2009
Quasiperiodicity and chaos in cardiac fibrillation.
1997
The Mechanisms of Atrial Fibrillation
2006
Idiopathic Paroxysmal Atrial Fibrillation Induced by a Focal Discharge Mechanism in the Left Superior Pulmonary Vein:
1999
Life-threatening alterations in heart rate after the use of adenosine in atrial flutter
1995
Role of the Posterior Papillary Muscle and Purkinje Potentials in the Mechanism of Ventricular Fibrillation in Open Chest Dogs and Swine: Effects of Catheter Ablation
2006
Clinical Significance of Early Recurrences of Atrial Tachycardia After Atrial Fibrillation Ablation
2010
Genetic and Environmental Influences on Echocardiographically Determined Left Ventricular Mass in Black Twins
1990
Is Empirical Four Pulmonary Vein Isolation Necessary for Focally Triggered Paroxysmal Atrial Fibrillation? Comparison of Selective Pulmonary Vein Isolation Versus Empirical Four Pulmonary Vein Isolation
2008
Circadian variation of blood pressure in blacks: influence of age, gender and activity.
1990
Interaction Between Strong Electrical Stimulation and Reentrant Wavefronts in Canine Ventricular Fibrillation
1995
Relation Between Ligament of Marshall and Adrenergic Atrial Tachyarrhythmia
1999
Vein of Marshall Cannulation for the Analysis of Electrical Activity in Patients With Focal Atrial Fibrillation
2000
\E Induction of Meandering Functional Reentrant Wave Front in Isolated Human Atrial Tissues
1997
Reentrant Wave Fronts in Wiggers’ Stage II Ventricular Fibrillation
1996
Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction
2008
A validation study of the Del Mar Avionics Pressurometer IV according to AAMI guidelines
1988
Programming of Implantable Cardioverter-Defibrillators on the Basis of the Upper Limit of Vulnerability
1997
Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs
2010